Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Natasha, Halasa"'
Autor:
Andy Liu, Alexa Love, Sophie Katz, Anna Patrick, David Parra, Natasha Halasa, Michael R. Miller
Publikováno v:
Pediatric Rheumatology Online Journal, Vol 20, Iss 1, Pp 1-5 (2022)
Abstract Background Multisystem inflammatory syndrome in children (MIS-C) is a febrile syndrome that is observed in the pediatric population following severe acute respiratory syndrome 2 (SARS-CoV-2) infection. Vaccines have prevented or lessened the
Externí odkaz:
https://doaj.org/article/241a69c4d7144d58950d9fdb739afa1d
Publikováno v:
Infectious Diseases and Therapy, Vol 10, Iss 1, Pp 595-603 (2020)
Abstract Introduction The kinetics of procalcitonin in pediatric patients with non-critical acute bacterial infections receiving appropriate antibiotic therapy are not well described. Methods We performed a single-center, prospective observational pi
Externí odkaz:
https://doaj.org/article/7e1bf6d87ca544aeb0c2002d18fa9878
Autor:
Julio A. Guerra, Chengxian Zhang, Jonathan E. Bard, Donald Yergeau, Natasha Halasa, Oscar G. Gómez-Duarte
Publikováno v:
BMC Genomics, Vol 21, Iss 1, Pp 1-13 (2020)
Abstract Background Shiga toxin-producing E. coli (STECs) are foodborne pathogens associated with bloody diarrhea and hemolytic uremic syndrome (HUS). Although the STEC O157 serogroup accounts for the highest number of infections, HUS-related complic
Externí odkaz:
https://doaj.org/article/90cae82322934752803e38a92743a1e3
Autor:
Manish Patel, Jufu Chen, Sara Kim, Shikha Garg, Brendan Flannery, Zaid Haddadin, Danielle Rankin, Natasha Halasa, H. Keipp Talbot, Carrie Reed
Publikováno v:
Emerging Infectious Diseases, Vol 26, Iss 8, Pp 1720-1730 (2020)
Increasing use of immunosuppressive biologic therapies poses a challenge for infectious diseases. Immunosuppressed patients have a high risk for influenza complications and an impaired immune response to vaccines. The total burden of immunosuppressiv
Externí odkaz:
https://doaj.org/article/05c19f0e10fe4c62aaf916b3d848b655
Autor:
Sameed M. Siddiqui, Kathryn A. Bowman, Alex L. Zhu, Stephanie Fischinger, Samuel Beger, Jenny S. Maron, Yannic C. Bartsch, Caroline Atyeo, Matthew J. Gorman, Ahmad Yanis, Judd F. Hultquist, Ramon Lorenzo-Redondo, Egon A. Ozer, Lacy M. Simons, Rana Talj, Danielle A. Rankin, Lindsay Chapman, Kyle Meade, Jordan Steinhart, Sean Mullane, Suzanne Siebert, Hendrik Streeck, Pardis Sabeti, Natasha Halasa, Elon R. Musk, Dan H. Barouch, Anil S. Menon, Eric J. Nilles, Douglas A. Lauffenburger, Galit Alter
Publikováno v:
mBio, Vol 13, Iss 1 (2022)
ABSTRACT As public health guidelines throughout the world have relaxed in response to vaccination campaigns against SARS-CoV-2, it is likely that SARS-CoV-2 will remain endemic, fueled by the rise of more infectious SARS-CoV-2 variants. Moreover, in
Externí odkaz:
https://doaj.org/article/b5339b2e730845f483424914beabf627
Autor:
Sophie E. Katz, Laura F. Sartori, Andras Szeles, Rendie McHenry, J. Eric Stanford, Meng Xu, Jennifer M. Colby, Natasha Halasa, Derek J. Williams, Ritu Banerjee
Publikováno v:
Infectious Diseases and Therapy, Vol 8, Iss 3, Pp 463-468 (2019)
Abstract Introduction Agreement between available procalcitonin (PCT) assays is unclear. We sought to compare concordance between Roche and bioMérieux PCT assays using pediatric samples. Methods We evaluated 213 plasma samples from 208 children. We
Externí odkaz:
https://doaj.org/article/0625536264a34914a4171bcf98e00929
Autor:
Kate Clouse, Asem Shehabi, Abel Mani Suleimat, Samir Faouri, Najwa Khuri-Bulos, Abeer Al Jammal, James Chappell, Kimberly B. Fortner, Anna B. Chamby, Tara M. Randis, Adam J. Ratner, David M. Aronoff, Natasha Halasa
Publikováno v:
BMC Pregnancy and Childbirth, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Background Little is known of the burden of Group B Streptococcus (GBS) colonization among pregnant women in Jordan. We conducted a pilot study to determine the prevalence of GBS among pregnant women in Amman, Jordan, where GBS testing is no
Externí odkaz:
https://doaj.org/article/131588cca0884d07b3a7c54f13f78b20
Autor:
Caitlin Turbyfill, Katherine Adams, Mark W. Tenforde, Nancy L. Murray, Manjusha Gaglani, Adit A. Ginde, Tresa McNeal, Shekhar Ghamande, David J. Douin, H. Keipp Talbot, Jonathan D. Casey, Nicholas M. Mohr, Anne Zepeski, Nathan I. Shapiro, Kevin W. Gibbs, D. Clark Files, David N. Hager, Arber Shehu, Matthew E. Prekker, Anne E. Frosch, Matthew C. Exline, Michelle N. Gong, Amira Mohamed, Nicholas J. Johnson, Vasisht Srinivasan, Jay S. Steingrub, Ithan D. Peltan, Samuel M. Brown, Emily T. Martin, Adam S. Lauring, Akram Khan, Laurence W. Busse, Caitlin C. ten Lohuis, Abhijit Duggal, Jennifer G. Wilson, Alexandra June Gordon, Nida Qadir, Steven Y. Chang, Christopher Mallow, Carolina Rivas, Jennie H. Kwon, Natasha Halasa, James D. Chappell, Carlos G. Grijalva, Todd W. Rice, William B. Stubblefield, Adrienne Baughman, Jillian P. Rhoads, Christopher J. Lindsell, Kimberly W. Hart, Meredith McMorrow, Diya Surie, Wesley H. Self, Manish M. Patel
Publikováno v:
Vaccine, vol 40, iss 48
BackgroundTest-negative design (TND) studies have produced validated estimates of vaccine effectiveness (VE) for influenza vaccine studies. However, syndrome-negative controls have been proposed for differentiating bias and true estimates in VE evalu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f3d4d9eebaaa287a091629da3368667
https://doi.org/10.1016/j.vaccine.2022.10.034
https://doi.org/10.1016/j.vaccine.2022.10.034
Autor:
Diya, Surie, Levi, Bonnell, Katherine, Adams, Manjusha, Gaglani, Adit A, Ginde, David J, Douin, H Keipp, Talbot, Jonathan D, Casey, Nicholas M, Mohr, Anne, Zepeski, Tresa, McNeal, Shekhar, Ghamande, Kevin W, Gibbs, D Clark, Files, David N, Hager, Arber, Shehu, Anne P, Frosch, Heidi L, Erickson, Michelle N, Gong, Amira, Mohamed, Nicholas J, Johnson, Vasisht, Srinivasan, Jay S, Steingrub, Ithan D, Peltan, Samuel M, Brown, Emily T, Martin, Akram, Khan, William S, Bender, Abhijit, Duggal, Jennifer G, Wilson, Nida, Qadir, Steven Y, Chang, Christopher, Mallow, Carolina, Rivas, Jennie H, Kwon, Matthew C, Exline, Adam S, Lauring, Nathan I, Shapiro, Natasha, Halasa, James D, Chappell, Carlos G, Grijalva, Todd W, Rice, William B, Stubblefield, Adrienne, Baughman, Kelsey N, Womack, Kimberly W, Hart, Sydney A, Swan, Yuwei, Zhu, Jennifer, DeCuir, Mark W, Tenforde, Manish M, Patel, Meredith L, McMorrow, Wesley H, Self, Carleigh, Samuels
Publikováno v:
MMWR. Morbidity and Mortality Weekly Report. 71:1327-1334
The SARS-CoV-2 Omicron variant (B.1.1.529 or BA.1) became predominant in the United States by late December 2021 (1). BA.1 has since been replaced by emerging lineages BA.2 (including BA.2.12.1) in March 2022, followed by BA.4 and BA.5, which have ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::198a0fb85e6ad0bdec844161784e9cab
https://doi.org/10.15585/mmwr.mm7142a3
https://doi.org/10.15585/mmwr.mm7142a3
Autor:
Jennifer E. Schuster, Lubna Hamdan, Daniel E. Dulek, Carrie L. Kitko, Einas Batarseh, Zaid Haddadin, Laura S. Stewart, Anna Stahl, Molly Potter, Herdi Rahman, Spyros A. Kalams, Susan Coffin, Monica I. Ardura, Rachel L. Wattier, Gabriela Maron, Claire E. Bocchini, Elizabeth A. Moulton, Michael Grimley, Grant Paulsen, Christopher J. Harrison, Jason Freedman, Paul A. Carpenter, Janet A. Englund, Flor M. Munoz, Lara Danziger-Isakov, Andrew J. Spieker, Natasha Halasa
Publikováno v:
New England Journal of Medicine. 388:374-376
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3c3e747ea0375929b50c5f5f41ff6b8
https://doi.org/10.1056/nejmc2210825
https://doi.org/10.1056/nejmc2210825